Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Mounjaro can make you feel sick, particularly in the first few weeks of treatment or after a dose increase. Nausea is the most commonly reported side effect, affecting a sizeable proportion of people who take tirzepatide. It tends to be mild to moderate, usually settles within days to two weeks, and is far less likely to persist at steady dose. That said, it is a real experience (not a sign something has gone wrong) and there are practical ways to make it more manageable. Like all medicines in this class, Mounjaro is a prescription-only treatment that requires clinical assessment before a prescriber decides whether it is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro activates two gut-hormone receptors, GIP and GLP-1, that are involved in appetite signalling and the rate at which your stomach empties. Slowing gastric emptying is part of how the medicine reduces hunger — food stays in your stomach longer, so fullness arrives sooner. The downside of that same mechanism is nausea, particularly when your system is first encountering the drug or adjusting to a higher dose. Your gut simply notices something has changed.
This is a question our prescribers hear most weeks, and the honest answer is: it is not random. The nausea is mechanistic. It follows the dose pattern. People who start at 2.5mg and titrate gradually (as the licensed schedule is designed) generally find the nausea milder than those who have had a dose jump without adequate time to adjust. The full Mounjaro side-effect profile covers more than nausea, but nausea is consistently what patients raise first.
The NHS patient information page for tirzepatide lists nausea, vomiting, diarrhoea, constipation and indigestion as the most common gastrointestinal effects, and confirms they are typically most intense at the start of treatment or after a dose step-up. Worth knowing: nausea from Mounjaro is not caused by the injection itself, it is a systemic effect of the medicine, not a local reaction at the injection site.
For most people, the nausea that arrives with a new dose eases substantially within one to two weeks. The pattern tends to repeat in a milder form each time the dose increases, a brief window of adjustment, then settling again. Some people notice very little at any point. Others find one particular dose step harder than the rest, then have no further trouble.
A smaller number of people do find nausea more persistent. If it is ongoing, that conversation belongs with your prescriber, who can consider whether a slower titration pace, anti-nausea support, or a change in timing might help. Stopping and restarting treatment without medical guidance is not recommended, missed doses and abrupt changes have their own effects.
There is also a related but distinct question: why nausea can come and go rather than following a clean linear pattern. Timing of meals relative to the injection, alcohol intake, and other medicines can all play a part. For people specifically wondering whether their experience is typical or whether something else might be going on, this deeper look at feeling sick on Mounjaro may answer that.
Tirzepatide is not the only GLP-1 class medicine that causes nausea, semaglutide does too. If you are curious how the two compare, the tirzepatide nausea page approaches the same question from a molecule-level angle.
The evidence-based advice for managing nausea on Mounjaro sits in a handful of consistent habits rather than any single fix. Smaller, more frequent meals reduce the load on a stomach that is already emptying slowly, a large plate of food on an already-sluggish gut is the worst combination. Fatty, rich, or spicy food tends to amplify symptoms, so many people find it worth adjusting what they eat around injection day rather than how much.
Eating slowly, chewing thoroughly, and not lying down immediately after a meal all help. Staying hydrated matters, not because water neutralises nausea, but because vomiting and reduced appetite together make dehydration a real risk, and dehydration makes nausea worse. Cold or room-temperature drinks are often better tolerated than hot ones when nausea is active.
Some people find that injecting on an evening rather than a morning, so any peak nausea happens overnight, suits them better. Others do the reverse. There is no single correct timing; the prescriber can help you find the pattern that works. For a related symptom that often travels with nausea, the page on managing sulphur burps on Mounjaro covers the dietary adjustments in more detail.
One note on fatigue: nausea and tiredness often appear together in the early weeks, partly because eating less and feeling unwell is physically draining. The connection between Mounjaro and fatigue is worth reading if both are present.
Ordinary nausea (queasiness, mild vomiting, feeling off food) is uncomfortable but not dangerous. It does not require urgent help. What does require prompt medical attention is severe, persistent stomach pain, particularly pain that radiates through to the back, with or without vomiting. This is the key symptom pattern for pancreatitis, a known but uncommon side effect of GLP-1 medicines. In January 2026 the MHRA issued a Drug Safety Update specifically highlighting acute pancreatitis across this medicine class and advising patients to seek urgent care if they experience that symptom pattern, you can report unexpected side effects via the MHRA's Yellow Card scheme.
Other signs that go beyond typical nausea and warrant a call to your prescriber or GP: symptoms of dehydration (dizziness, very dark urine, inability to keep fluids down), signs of a gallbladder problem (severe upper-right abdominal pain), or any allergic reaction. Do not manage these with over-the-counter nausea remedies alone.
If you are considering starting Mounjaro and want to understand the full picture before you do, our Mounjaro treatment overview and the weight-loss treatment options page both set out what clinical assessment involves. For context on what treatment costs in the UK private market, the Mounjaro price page covers that honestly. When you are ready to speak to a prescriber, starting your free consultation is the next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.